Selim Nalbant
- Nephrology top 5%
- Rheumatology top 5%
- Urticaria and Related Conditions 3
- Rheumatoid Arthritis Research and Therapies 3
- Molecular Medicine top 10%
- Endocrinology top 10%
-
- Autoimmune and Inflammatory Disorders Research 4
-
- Inflammasome and immune disorders 7
-
- Inflammatory mediators and NSAID effects 4
-
- Inflammatory Biomarkers in Disease Prognosis 3
-
- Nutrition and Health in Aging 3
-
- interferon and immune responses 2
- Co-authors
- Tasanee KitumnuaypongH. Ralph SchumacherM. SieckGilda ClayburneYaşar KüçükardalıJose A. MartinezÇağatay ÖktenliHakan Terekeci
- Journals
- BMC Genomics (1 paper)Osteoarthritis and Cartilage (1 paper)Journal of Hospital Infection (1 paper)
- Partner nations
- TürkiyeUnited StatesSerbia
In The Last Decade
Selim Nalbant
42 papers receiving 839 citations
Peers
Comparison fields: 5 of 119
- Nephrology 142
- Rheumatology 263
- Molecular Medicine 51
- Endocrinology 37
- Hematology 56
Countries citing papers authored by Selim Nalbant
This map shows the geographic impact of Selim Nalbant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selim Nalbant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selim Nalbant more than expected).
Fields of papers citing papers by Selim Nalbant
This network shows the impact of papers produced by Selim Nalbant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selim Nalbant. The network helps show where Selim Nalbant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Selim Nalbant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 0 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 2 | |
| 4 | 2020 | 10 | |
| 5 | 2020 | 2 | |
| 6 | 2015 | 2 | |
| 7 | 2012 | 70 | |
| 8 | 2012 | 14 | |
| 9 | Mean Platelet Volume (MPV) in Intensive Care Unit (ICU) Patients: Is it a useful parameter in assessing prediction for mortality? | 2010 | 9 |
| 10 | 2010 | 7 | |
| 11 | Hemofagositik Sendrom ve Fulminan Hepatit ile Seyreden Nedeni Bilinmeyen Ateş Olgusu: Erişkin Still Hastalığı | 2009 | 1 |
| 12 | 2009 | 33 | |
| 13 | 2008 | 11 | |
| 14 | 2007 | 2 | |
| 15 | Çorum İli ve Çevresinde Ailesel Akdeniz Ateşi Artriti Olarak Farklı Bir Fenotip mi Var | 2006 | 0 |
| 16 | 2005 | 113 | |
| 17 | 2005 | 11 | |
| 18 | 2005 | 3 | |
| 19 | 2002 | 8 | |
| 20 | Serotonin syndrome caused by moclobemide-clomipramine interaction | 2001 | 1 |
About Selim Nalbant
Selim Nalbant is a scholar working on Rheumatology, Hematology and Gastroenterology, having authored 44 papers that have together received 868 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Inflammatory mediators and NSAID effects (4 papers), Urticaria and Related Conditions (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Nutrition and Health in Aging (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Nephrology (142 citations), Rheumatology (263 citations) and Molecular Medicine (51 citations). Selim Nalbant has collaborated with scholars based in Türkiye, United States and Serbia. Frequent co-authors include Tasanee Kitumnuaypong, H. Ralph Schumacher, M. Sieck, Gilda Clayburne, Yaşar Küçükardalı, Jose A. Martinez, Çağatay Öktenli, Hakan Terekeci, Özkan Sayan and Cihan Top. Their work appears in journals such as BMC Genomics, Osteoarthritis and Cartilage and Journal of Hospital Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.